![John Charles Harrington](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Charles Harrington
Chief Executive Officer at Harrington Investments, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Shay Way Seng | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Claude Wischik | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | 22 years |
Kin Meng Wong | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Hong Wei Hwang | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | 14 years |
John Anderson Storey | M | 52 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Glenn Andrew Corr | M | 54 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | 4 years |
Paul Cheng | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | 7 years |
Brianna Harrington | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | 8 years |
Jeff Field | M | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | 9 years |
Siew Choon Tay | M | 77 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
George Chia | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Kok Thay Lim | M | 72 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Stephen Logan | M | - |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Huai Dan Chen | F | 57 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Sushilan Vasoo | M | 83 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Kong Han Tan | M | 58 |
TauRx Pharmaceuticals Ltd.
![]() TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | - |
Patricia Boss | F | - |
Caniccor
| - |
Rebecca White | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Forrest Hill | M | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Rebecca Long | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Dale Wannen | M | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Susan Bogar | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Virginia Cao Janos | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | 2 years |
Jack Ucciferri | M | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | 2 years |
Monica Nelson | F | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | - |
Susan Hilary Ozawa Perez | M | - |
Harrington Investments, Inc.
![]() Harrington Investments, Inc. Investment ManagersFinance Founded in 1982, Harrington Investments, Inc. is a wealth management firm and registered investment advisor located in Napa, California. The firm manages assets for institutional and individual investors. | 2 years |
Yoshimune Yamaoka | M | 43 |
Dominican University (Illinois)
| 1 years |
Abdullah Al-Issa | M | 47 |
Dominican University (Illinois)
| 2 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 14 | 50.00% |
Singapore | 14 | 50.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- John Charles Harrington
- Personal Network